首页 > 最新文献

Current Cardiovascular Risk Reports最新文献

英文 中文
The Genetics of Inheritable Aortic Diseases 遗传性主动脉疾病的遗传学
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-02-01 DOI: 10.1007/s12170-022-00687-x
A. Kalyanasundaram, J. Elefteriades
{"title":"The Genetics of Inheritable Aortic Diseases","authors":"A. Kalyanasundaram, J. Elefteriades","doi":"10.1007/s12170-022-00687-x","DOIUrl":"https://doi.org/10.1007/s12170-022-00687-x","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"13-24"},"PeriodicalIF":1.9,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47708188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Disparities in the Use of Cardiac Rehabilitation in African Americans. 非裔美国人心脏康复使用的差异
IF 2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 Epub Date: 2022-05-07 DOI: 10.1007/s12170-022-00690-2
Lena Mathews, Ofure Akhiwu, Monica Mukherjee, Roger S Blumenthal, Kunihiro Matsushita, Chiadi E Ndumele

Purpose of review: Cardiac rehabilitation (CR) is a comprehensive outpatient program that reduces the risk of mortality and recurrent events and improves functional status and quality of life for patients recovering from acute cardiovascular disease (CVD) events. Among individuals with established CVD, African Americans have a higher risk of major cardiac events, which underscores the importance of CR use among African Americans. However, despite their high likelihood of adverse outcomes, CR is poorly utilized in African Americans with CVD. We review data on CR utilization among African Americans, barriers to participation, and the implications for policy and practice.

Recent findings: Although established as a highly effective secondary prevention strategy, CR is underutilized in general, but especially by African Americans. Notwithstanding efforts to increase CR participation among all groups, participation rates remain low for African Americans and other minorities compared to Non-Hispanic Whites. The low CR participation rates by African Americans can be attributed to an array of factors including differential referral patterns, access to care, and socioeconomic factors. There are several promising strategies to improve CR participation which include promoting evidence-based guidelines, reducing barriers to access, novel CR delivery modalities, including more African Americans in CR clinical research, and increasing diversity in the CR workforce.

Summary: African Americans with CVD events are less likely to be referred to, enroll in, and complete CR than Non-Hispanic Whites. There are many factors that impact CR participation by African Americans. Initiatives at the health policy, health system, individual, and community level will be needed to reduce these disparities in CR use.

审查目的:心脏康复(CR)是一项综合性门诊计划,可降低急性心血管疾病(CVD)患者的死亡率和复发风险,改善其功能状态和生活质量。在已确诊的心血管疾病患者中,非裔美国人发生重大心脏事件的风险较高,这凸显了 CR 在非裔美国人中使用的重要性。然而,尽管非裔美国人发生不良后果的可能性很高,但他们对心血管疾病 CR 的利用率却很低。我们回顾了非裔美国人使用 CR 的数据、参与 CR 的障碍以及对政策和实践的影响:最近的研究结果:尽管 CR 被认为是一种非常有效的二级预防策略,但它的利用率普遍较低,尤其是在非裔美国人中。尽管我们努力提高所有群体的 CR 参与率,但与非西班牙裔白人相比,非裔美国人和其他少数民族的参与率仍然很低。非裔美国人的 CR 参与率低可归因于一系列因素,包括不同的转诊模式、获得护理的机会以及社会经济因素。提高 CR 参与率有几种可行的策略,其中包括推广循证指南、减少就医障碍、采用新颖的 CR 治疗模式、让更多非裔美国人参与 CR 临床研究以及增加 CR 工作人员的多样性。摘要:与非西班牙裔白人相比,患有心血管疾病的非裔美国人被转诊、加入和完成 CR 的可能性较低。影响非裔美国人参与 CR 的因素有很多。需要在卫生政策、卫生系统、个人和社区层面采取措施,以减少 CR 使用方面的这些差异。
{"title":"Disparities in the Use of Cardiac Rehabilitation in African Americans.","authors":"Lena Mathews, Ofure Akhiwu, Monica Mukherjee, Roger S Blumenthal, Kunihiro Matsushita, Chiadi E Ndumele","doi":"10.1007/s12170-022-00690-2","DOIUrl":"10.1007/s12170-022-00690-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>Cardiac rehabilitation (CR) is a comprehensive outpatient program that reduces the risk of mortality and recurrent events and improves functional status and quality of life for patients recovering from acute cardiovascular disease (CVD) events. Among individuals with established CVD, African Americans have a higher risk of major cardiac events, which underscores the importance of CR use among African Americans. However, despite their high likelihood of adverse outcomes, CR is poorly utilized in African Americans with CVD. We review data on CR utilization among African Americans, barriers to participation, and the implications for policy and practice.</p><p><strong>Recent findings: </strong>Although established as a highly effective secondary prevention strategy, CR is underutilized in general, but especially by African Americans. Notwithstanding efforts to increase CR participation among all groups, participation rates remain low for African Americans and other minorities compared to Non-Hispanic Whites. The low CR participation rates by African Americans can be attributed to an array of factors including differential referral patterns, access to care, and socioeconomic factors. There are several promising strategies to improve CR participation which include promoting evidence-based guidelines, reducing barriers to access, novel CR delivery modalities, including more African Americans in CR clinical research, and increasing diversity in the CR workforce.</p><p><strong>Summary: </strong>African Americans with CVD events are less likely to be referred to, enroll in, and complete CR than Non-Hispanic Whites. There are many factors that impact CR participation by African Americans. Initiatives at the health policy, health system, individual, and community level will be needed to reduce these disparities in CR use.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"31-41"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46254163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care. 第四孕期:加强心血管护理过渡的时机。
IF 2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 Epub Date: 2022-09-21 DOI: 10.1007/s12170-022-00706-x
Eunjung Choi, Brigitte Kazzi, Bhavya Varma, Alexandra R Ortengren, Anum S Minhas, Arthur Jason Vaught, Wendy L Bennett, Jennifer Lewey, Erin D Michos

Purpose of review: The "fourth trimester" concept, defined as the first 12 weeks after delivery (and beyond), is a critical window of time for clinicians to intervene to optimize women's cardiovascular health after pregnancy. A timely and comprehensive postpartum cardiovascular assessment should be performed in all women following delivery in order to (1) follow up medical conditions present prior to conception, (2) evaluate symptoms and signs of common postpartum complications, and (3) identify risk factors and prevent future adverse cardiovascular outcomes. In this review, we aim to discuss major maternal cardiovascular risk factors such as hypertensive disorders of pregnancy, gestational diabetes mellitus, postpartum weight retention, and postpartum depression, as well as lactation as a potential protective risk modifying factor. Additionally, we will review effectiveness of outpatient interventions to enhance transitions in cardiovascular care during the fourth trimester.

Recent findings: A seamless hand-off from obstetric to primary care, and potentially cardiology, is needed for early detection and management of hypertension, weight, glycemic control, stress and mood, and long-term cardiovascular risk. Additionally, the use of telemedicine, blood pressure self-monitoring, remote activity monitoring, and behavioral health coaches are potentially feasible modalities to augment clinic-based care for cardiovascular risk factors and weight management, but additional studies are needed to study their long-term effectiveness.

Summary: Development of a comprehensive postpartum care plan with careful consideration of each patient's risk profile and access to resources is critical to improve maternal morbidity and mortality, reduce health disparities, and achieve long-term cardiovascular health for women. Supporting postpartum well-being of women during this transition period requires a multidisciplinary approach, especially primary care engagement, and planning should start before delivery.

回顾的目的:第四孕期 "的概念是指分娩后的前 12 周(及以后),这是临床医生进行干预以优化妇女妊娠后心血管健康的关键时间窗口。所有产后妇女都应进行及时、全面的产后心血管评估,以便:(1)跟踪受孕前的医疗状况;(2)评估常见产后并发症的症状和体征;(3)识别风险因素并预防未来不良心血管结局的发生。在这篇综述中,我们旨在讨论主要的产妇心血管风险因素,如妊娠高血压、妊娠糖尿病、产后体重潴留和产后抑郁,以及作为潜在保护性风险调节因素的哺乳。此外,我们还将回顾门诊干预措施的有效性,以加强第四孕期心血管护理的过渡:最近的研究结果:从产科到初级保健,甚至是心内科的无缝衔接是早期发现和管理高血压、体重、血糖控制、压力和情绪以及长期心血管风险所必需的。此外,使用远程医疗、血压自我监测、远程活动监测和行为健康指导也是潜在的可行方式,可增强诊所对心血管风险因素和体重管理的护理,但还需要更多的研究来探讨其长期有效性。总结:制定全面的产后护理计划,并仔细考虑每位患者的风险状况和资源获取情况,对于改善孕产妇发病率和死亡率、减少健康差异和实现妇女长期心血管健康至关重要。要在这一过渡时期为妇女的产后健康提供支持,需要采取多学科的方法,尤其是初级保健的参与,而且规划应在分娩前就开始。
{"title":"The Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care.","authors":"Eunjung Choi, Brigitte Kazzi, Bhavya Varma, Alexandra R Ortengren, Anum S Minhas, Arthur Jason Vaught, Wendy L Bennett, Jennifer Lewey, Erin D Michos","doi":"10.1007/s12170-022-00706-x","DOIUrl":"10.1007/s12170-022-00706-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>The \"fourth trimester\" concept, defined as the first 12 weeks after delivery (and beyond), is a critical window of time for clinicians to intervene to optimize women's cardiovascular health after pregnancy. A timely and comprehensive postpartum cardiovascular assessment should be performed in all women following delivery in order to (1) follow up medical conditions present prior to conception, (2) evaluate symptoms and signs of common postpartum complications, and (3) identify risk factors and prevent future adverse cardiovascular outcomes. In this review, we aim to discuss major maternal cardiovascular risk factors such as hypertensive disorders of pregnancy, gestational diabetes mellitus, postpartum weight retention, and postpartum depression, as well as lactation as a potential protective risk modifying factor. Additionally, we will review effectiveness of outpatient interventions to enhance transitions in cardiovascular care during the fourth trimester.</p><p><strong>Recent findings: </strong>A seamless hand-off from obstetric to primary care, and potentially cardiology, is needed for early detection and management of hypertension, weight, glycemic control, stress and mood, and long-term cardiovascular risk. Additionally, the use of telemedicine, blood pressure self-monitoring, remote activity monitoring, and behavioral health coaches are potentially feasible modalities to augment clinic-based care for cardiovascular risk factors and weight management, but additional studies are needed to study their long-term effectiveness.</p><p><strong>Summary: </strong>Development of a comprehensive postpartum care plan with careful consideration of each patient's risk profile and access to resources is critical to improve maternal morbidity and mortality, reduce health disparities, and achieve long-term cardiovascular health for women. Supporting postpartum well-being of women during this transition period requires a multidisciplinary approach, especially primary care engagement, and planning should start before delivery.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 12","pages":"219-229"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10600408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Sudden Death in Athletes, Is There a Role for Screening? 运动员猝死的风险因素,筛查有作用吗?
IF 2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 Epub Date: 2022-07-04 DOI: 10.1007/s12170-022-00697-9
Alexander G Hajduczok, Max Ruge, Michael S Emery

Purpose of review: Sudden cardiac death (SCD) in a young athlete is an infrequent yet devastating event often associated with substantial media attention. Screening athletes for conditions associated with SCD is a controversial topic with debate surrounding virtually each component including the ideal subject, method, and performer/interpreter of such screens. In fact, major medical societies such as the American College of Cardiology/American Heart Association and the European Society of Cardiology have discrepant recommendations on the matter, and major sporting associations have enacted a wide range of screening policies, highlighting the confusion on this subject. This review seeks to summarize the literature in this area to address the complex and disputed subject of screening young athletes for SCD.

Recent findings: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause myocarditis, which is one acquired cardiac disease associated with SCD. The coronavirus 2019 (COVID-19) pandemic has therefore resulted in an increased incidence of an otherwise less common condition, providing an expanded dataset for further study of this condition. Recent findings indicate that cardiac complications of athletes with myocardial involvement of SARS-CoV-2 infection are rare. Other contemporary work in SCD screening has been focused on the implementation of various screening protocols and measuring their effectiveness.

Summary: No universal consensus exists for athlete screening for conditions associated with SCD with varying guidelines and protocols across cardiology and sport-specific organizations. No screening program will prevent all SCD; however, small programs managed by physicians familiar with the examination of an athlete that carefully personalize screening to the individual may maximize detection of dangerous cardiac conditions while minimizing false positives.

审查目的:年轻运动员的心脏性猝死(SCD)事件并不常见,但却具有毁灭性,往往会引起媒体的高度关注。对运动员进行与 SCD 相关的疾病筛查是一个有争议的话题,几乎每个环节都存在争论,包括筛查的理想对象、方法和执行者/解释者。事实上,美国心脏病学会/美国心脏协会和欧洲心脏病学会等主要医学协会在此问题上的建议并不一致,而主要的体育协会也颁布了各种筛查政策,凸显了在此问题上的混乱。本综述旨在总结该领域的文献,以解决年轻运动员 SCD 筛查这一复杂而有争议的问题:严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)可引起心肌炎,这是一种与 SCD 相关的后天性心脏病。因此,冠状病毒 2019(COVID-19)大流行导致这种原本不太常见的疾病发病率增加,为进一步研究这种疾病提供了更多的数据集。最近的研究结果表明,SARS-CoV-2 感染累及心肌的运动员心脏并发症很少见。小结:对于运动员筛查与 SCD 相关的疾病,目前还没有达成普遍共识,心脏病学和特定运动组织的指导方针和方案也各不相同。没有任何筛查方案可以预防所有的 SCD;但是,由熟悉运动员检查的医生管理的小型方案,根据个人情况仔细进行个性化筛查,可以最大限度地发现危险的心脏疾病,同时最大限度地减少假阳性。
{"title":"Risk Factors for Sudden Death in Athletes, Is There a Role for Screening?","authors":"Alexander G Hajduczok, Max Ruge, Michael S Emery","doi":"10.1007/s12170-022-00697-9","DOIUrl":"10.1007/s12170-022-00697-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Sudden cardiac death (SCD) in a young athlete is an infrequent yet devastating event often associated with substantial media attention. Screening athletes for conditions associated with SCD is a controversial topic with debate surrounding virtually each component including the ideal subject, method, and performer/interpreter of such screens. In fact, major medical societies such as the American College of Cardiology/American Heart Association and the European Society of Cardiology have discrepant recommendations on the matter, and major sporting associations have enacted a wide range of screening policies, highlighting the confusion on this subject. This review seeks to summarize the literature in this area to address the complex and disputed subject of screening young athletes for SCD.</p><p><strong>Recent findings: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause myocarditis, which is one acquired cardiac disease associated with SCD. The coronavirus 2019 (COVID-19) pandemic has therefore resulted in an increased incidence of an otherwise less common condition, providing an expanded dataset for further study of this condition. Recent findings indicate that cardiac complications of athletes with myocardial involvement of SARS-CoV-2 infection are rare. Other contemporary work in SCD screening has been focused on the implementation of various screening protocols and measuring their effectiveness.</p><p><strong>Summary: </strong>No universal consensus exists for athlete screening for conditions associated with SCD with varying guidelines and protocols across cardiology and sport-specific organizations. No screening program will prevent all SCD; however, small programs managed by physicians familiar with the examination of an athlete that carefully personalize screening to the individual may maximize detection of dangerous cardiac conditions while minimizing false positives.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 10","pages":"97-109"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40490329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Cardio-oncology Preventative Care: Racial and Ethnic Disparities 更正:心脏肿瘤预防护理:种族和民族差异
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.1007/s12170-022-00688-w
P. Prasad, Mary Branch, Daniel Asemota, Razan Elsayed, D. Addison, Sherry‐Ann Brown
{"title":"Correction to: Cardio-oncology Preventative Care: Racial and Ethnic Disparities","authors":"P. Prasad, Mary Branch, Daniel Asemota, Razan Elsayed, D. Addison, Sherry‐Ann Brown","doi":"10.1007/s12170-022-00688-w","DOIUrl":"https://doi.org/10.1007/s12170-022-00688-w","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"11"},"PeriodicalIF":1.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45300657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Technology Is Changing Interventional Cardiology 技术如何改变介入心脏病学
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-01-01 DOI: 10.1007/s12170-021-00686-4
Diala Steitieh, Nivita D Sharma, Harsimran S. Singh
{"title":"How Technology Is Changing Interventional Cardiology","authors":"Diala Steitieh, Nivita D Sharma, Harsimran S. Singh","doi":"10.1007/s12170-021-00686-4","DOIUrl":"https://doi.org/10.1007/s12170-021-00686-4","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"16 1","pages":"1-10"},"PeriodicalIF":1.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41822444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Patient Selection for Biventricular Cardiac Resynchronization Therapy, His Bundle Pacing, and Left Bundle Branch Pacing 双心室心脏再同步治疗、His束起搏和左束支起搏的患者选择
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-10-26 DOI: 10.1007/s12170-021-00684-6
David J Sanders, Kousik Krishnan
{"title":"Patient Selection for Biventricular Cardiac Resynchronization Therapy, His Bundle Pacing, and Left Bundle Branch Pacing","authors":"David J Sanders, Kousik Krishnan","doi":"10.1007/s12170-021-00684-6","DOIUrl":"https://doi.org/10.1007/s12170-021-00684-6","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2021-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42680708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in Computer Vision: Cardiac MRI and Multimodality Imaging Segmentation. 计算机视觉中的人工智能:心脏磁共振成像和多模态成像分割。
IF 2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-09-01 Epub Date: 2021-08-04 DOI: 10.1007/s12170-021-00678-4
Alan C Kwan, Gerran Salto, Susan Cheng, David Ouyang

Purpose of review: Anatomical segmentation has played a major role within clinical cardiology. Novel techniques through artificial intelligence-based computer vision have revolutionized this process through both automation and novel applications. This review discusses the history and clinical context of cardiac segmentation to provide a framework for a survey of recent manuscripts in artificial intelligence and cardiac segmentation. We aim to clarify for the reader the clinical question of "Why do we segment?" in order to understand the question of "Where is current research and where should be?".

Recent findings: There has been increasing research in cardiac segmentation in recent years. Segmentation models are most frequently based on a U-Net structure. Multiple innovations have been added in terms of pre-processing or connection to analysis pipelines. Cardiac MRI is the most frequently segmented modality, which is due in part to the presence of publically-available, moderately sized, computer vision competition datasets. Further progress in data availability, model explanation, and clinical integration are being pursued.

Summary: The task of cardiac anatomical segmentation has experienced massive strides forward within the past five years due to convolutional neural networks. These advances provide a basis for streamlining image analysis, and a foundation for further analysis both by computer and human systems. While technical advances are clear, clinical benefit remains nascent. Novel approaches may improve measurement precision by decreasing inter-reader variability and appear to also have the potential for larger-reaching effects in the future within integrated analysis pipelines.

综述目的:解剖分割在临床心脏病学中发挥了重要作用。基于人工智能的计算机视觉新技术通过自动化和新应用彻底改变了这一过程。这篇综述讨论了心脏分割的历史和临床背景,为近期人工智能和心脏分割领域的手稿调查提供了一个框架。我们旨在为读者澄清 "我们为什么要进行分割?"这一临床问题,从而理解 "当前的研究在哪里,应该在哪里?"这一问题:近年来,有关心脏分割的研究日益增多。细分模型大多基于 U-Net 结构。在预处理或与分析流水线的连接方面也有多种创新。心脏核磁共振成像是最常见的分段模式,部分原因是存在公开的、中等规模的计算机视觉竞赛数据集。摘要:由于卷积神经网络的出现,心脏解剖分割任务在过去五年中取得了巨大进步。这些进步为简化图像分析提供了基础,也为计算机和人类系统的进一步分析奠定了基础。虽然技术进步是显而易见的,但临床效益仍处于起步阶段。新方法可以通过减少读片者之间的差异来提高测量精度,而且似乎还有可能在未来的综合分析管道中产生更大的影响。
{"title":"Artificial Intelligence in Computer Vision: Cardiac MRI and Multimodality Imaging Segmentation.","authors":"Alan C Kwan, Gerran Salto, Susan Cheng, David Ouyang","doi":"10.1007/s12170-021-00678-4","DOIUrl":"10.1007/s12170-021-00678-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>Anatomical segmentation has played a major role within clinical cardiology. Novel techniques through artificial intelligence-based computer vision have revolutionized this process through both automation and novel applications. This review discusses the history and clinical context of cardiac segmentation to provide a framework for a survey of recent manuscripts in artificial intelligence and cardiac segmentation. We aim to clarify for the reader the clinical question of \"Why do we segment?\" in order to understand the question of \"Where is current research and where should be?\".</p><p><strong>Recent findings: </strong>There has been increasing research in cardiac segmentation in recent years. Segmentation models are most frequently based on a U-Net structure. Multiple innovations have been added in terms of pre-processing or connection to analysis pipelines. Cardiac MRI is the most frequently segmented modality, which is due in part to the presence of publically-available, moderately sized, computer vision competition datasets. Further progress in data availability, model explanation, and clinical integration are being pursued.</p><p><strong>Summary: </strong>The task of cardiac anatomical segmentation has experienced massive strides forward within the past five years due to convolutional neural networks. These advances provide a basis for streamlining image analysis, and a foundation for further analysis both by computer and human systems. While technical advances are clear, clinical benefit remains nascent. Novel approaches may improve measurement precision by decreasing inter-reader variability and appear to also have the potential for larger-reaching effects in the future within integrated analysis pipelines.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"15 9","pages":""},"PeriodicalIF":2.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187294/pdf/nihms-1807011.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9333806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary and Lifestyle Modification for the Prevention and Treatment of Hypertension 改变饮食和生活方式预防和治疗高血压
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-08-10 DOI: 10.1007/s12170-021-00683-7
Michael R. Goetsch, Anjali A Wagle, Evangelia Valilis, A. Razavi, J. McEvoy, R. Blumenthal, S. Whelton
{"title":"Dietary and Lifestyle Modification for the Prevention and Treatment of Hypertension","authors":"Michael R. Goetsch, Anjali A Wagle, Evangelia Valilis, A. Razavi, J. McEvoy, R. Blumenthal, S. Whelton","doi":"10.1007/s12170-021-00683-7","DOIUrl":"https://doi.org/10.1007/s12170-021-00683-7","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2021-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12170-021-00683-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48598544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophageal Injury and Progression to Atrial-Esophageal Fistula in Catheter Ablation for Atrial Fibrillation 心房颤动导管消融治疗食管损伤及进展为心房食管瘘
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-08-05 DOI: 10.1007/s12170-021-00681-9
Nashwa M Abdulsalam, N. Akoum
{"title":"Esophageal Injury and Progression to Atrial-Esophageal Fistula in Catheter Ablation for Atrial Fibrillation","authors":"Nashwa M Abdulsalam, N. Akoum","doi":"10.1007/s12170-021-00681-9","DOIUrl":"https://doi.org/10.1007/s12170-021-00681-9","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2021-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12170-021-00681-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47654952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Cardiovascular Risk Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1